CURE Update: Discover New Research and Attend Community Events
Pediatric Epilepsy
Diacomit is a new type of anticonvulsive medication that has been shown to reduce the frequency of seizures in patients with Dravet syndrome, especially when administered in combination with other antiseizure medications or with dietary interventions.
NIH awards $2.3 million to Dr. Nuri Ince to expand testing to dramatically decrease in the time it takes to detect the seizure onset zone (SOZ) in the brain
The aim of this systematic review is to synthesize the evidence regarding the perspectives of children and adolescents with PNES, and the perspectives of their parents, caregivers and families.
This study provides a brief overview of commonly used machine learning approaches, as well as challenges in further application of machine learning techniques in epilepsy.
These researchers assess three different seizure outcome measures (relative seizure reduction, absolute seizure reduction, and seizure freedom [yes/no]) to investigate which measure best predicts postoperative quality of life.
The midazolam administered as a single-dose nasal spray was superior to placebo in providing rapid, sustained seizure control when administered to patients experiencing an seizure clusters in the outpatient setting and was associated with a favorable safety profile.
CBD
MGC Pharmaceuticals has received Human Research Ethics Committee approval to conduct a head-to-head clinical study to compare the effectiveness of its low THC formula for the treatment of drug-resistant epilepsy to its 100% CBD product.
Study finds that public health campaigns targeting inactivity are warranted.
